Although both ESR and CRP are inflammatory markers that could increase in other infectious diseases, e.g., TB [32], their inclusion in the CoMPred indicator increased its sensitivity to predicting mortality among COVID-19 patients. The gene discussed is ESR1; the disease is tuberculosis.